Literature DB >> 12643400

Effect of off-pump coronary surgery with right ventricular assist device on organ function and inflammatory response: a randomized controlled trial.

Massimo Caputo1, Mark Yeatman, Pradeep Narayan, Giovanni Marchetto, Raimondo Ascione, Barnaby C Reeves, Gianni D Angelini.   

Abstract

BACKGROUND: Right ventricular assist devices (RVADs) have been proposed to improve exposure of the coronary arteries in off-pump surgery. In this study we investigated the impact of the A-Med RVAD on inflammatory response and organ function in patients undergoing coronary artery bypass grafting.
METHODS: Sixty patients were prospectively randomized to conventional surgery with cardiopulmonary bypass (CPB) and cardioplegic arrest, beating heart surgery (off-pump), or beating heart surgery with the RVAD. Serial blood samples were collected postoperatively, for analysis of inflammatory markers, troponin I, protein S100, and free hemoglobin. Renal tubular function was assessed by measuring urine N-acetyl-glucosaminidase activity.
RESULTS: No hospital deaths or major postoperative complications occurred in the study population. Interleukin-6, interleukin-8, C3a, and troponin I levels after surgery were significantly higher in the CPB group compared with the off-pump and RVAD groups. Free hemoglobin levels immediately after the operation, peak and total S100 levels, and N-acetyl-glucosaminidase activity were also significantly higher in the CPB group.
CONCLUSIONS: Off-pump coronary revascularization, with or without RVAD, reduces inflammatory response, myocardial, neurologic, and renal injury, and decreases hemolysis when compared with conventional surgery with CPB and cardioplegic arrest.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12643400     DOI: 10.1016/s0003-4975(02)04025-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

Review 2.  A systematic review of the quality of publications reporting coronary artery bypass grafting trials.

Authors:  Forough Farrokhyar; Rong Chu; Richard Whitlock; Lehana Thabane
Journal:  Can J Surg       Date:  2007-08       Impact factor: 2.089

Review 3.  Off-pump versus on-pump coronary artery bypass grafting.

Authors:  Christian H Møller; Daniel A Steinbrüchel
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

Review 4.  Meta-analysis of interleukin 6, 8, and 10 between off-pump and on-pump coronary artery bypass groups.

Authors:  Fanbo Meng; Jianghong Ma; Wei Wang; Baisong Lin
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

5.  Relationship between platelet mass index and postoperative atrial fibrillation after elective coronary artery bypass surgery: a retrospective study.

Authors:  Ozge Guzelburc; Ahmet Zengin; Mehmet Baran Karatas; Sevinc Bayer Erdogan; Ayse Emre
Journal:  Herz       Date:  2022-09-05       Impact factor: 1.740

6.  Percutaneous Double Lumen Cannula for Right Ventricle Assist Device System: A Computational Fluid Dynamics Study.

Authors:  Francesca Condemi; Dongfang Wang; Gionata Fragomeni; Fuqian Yang; Guangfeng Zhao; Cameron Jones; Cherry Ballard-Croft; Joseph B Zwischenberger
Journal:  Biocybern Biomed Eng       Date:  2016-04-18       Impact factor: 4.314

7.  The Effect of Patient-Specific Cerebral Oxygenation Monitoring on Postoperative Cognitive Function: A Multicenter Randomized Controlled Trial.

Authors:  Lucy Ellis; Gavin J Murphy; Lucy Culliford; Lucy Dreyer; Gemma Clayton; Richard Downes; Eamonn Nicholson; Serban Stoica; Barnaby C Reeves; Chris A Rogers
Journal:  JMIR Res Protoc       Date:  2015-12-18

8.  Systematic review of pre-clinical therapies for post-operative atrial fibrillation.

Authors:  Chanhee Seo; Connor Michie; Benjamin Hibbert; Darryl R Davis
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.